Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07042256
Recruiting
Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer
Not applicable · Switzerland · 1 site
Registry update: 6 Jul 2026
NCT07646847
Recruiting
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Not applicable · United States · 8 sites
Registry update: 28 Oct 2026
NCT06502171
Recruiting
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
Phase 1 · United States · 8 sites
Registry update: 2 Oct 2026
NCT07646197
Recruiting
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
Not applicable · United States · 1 site
Registry update: 6 Aug 2026
NCT07799519
Recruiting
Finerenone After Catheter Ablation to Reduce Atrial Fibrillation Recurrence
Phase 2 · Taiwan · 1 site
Registry update: 2 Sept 2026
NCT07643012
Recruiting
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
Not applicable · United States · 1 site
Registry update: 6 Jul 2026
NCT07889388
Recruiting
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study
Not applicable · Germany · 1 site
Registry update: 2 Nov 2026
NCT07562022
Recruiting
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Phase 3 · China · 1 site
Registry update: 13 Aug 2026
NCT07324837
Recruiting
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset
Phase 3 · Russia · 17 sites
Registry update: 1 Oct 2026
NCT07637825
Recruiting
Transcranial Focused Ultrasound Neuromodulation for Post-Stroke Motor Dysfunction
Not applicable · China · 1 site
Registry update: 6 Oct 2026
NCT05982496
Recruiting
18F-FES PET/MRI for tailoring treatment of luminal A and lobular breast cancer: a phase II trial evaluating the performance of FES PET/MRI in axillary staging
Phase 2 · Italy · 1 site
Registry update: 27 Mar 2026
NCT07475026
Recruiting
A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence
Phase 3 · China · 1 site
Registry update: 5 Aug 2026
NCT07656571
Recruiting
Indocyanine Green-Guided Versus Standard Laparoscopic Distal Pancreatectomy for Pancreatic Body and Tail Lesions
Not applicable · Egypt · 1 site
Registry update: 18 Jun 2026
NCT07819747
Recruiting
Resources and Education for Addressing Chronic Health (REACH)
Not applicable · United States · 1 site
Registry update: 21 Sept 2026
NCT07362966
Recruiting
Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis
Phase 4 · China · 1 site
Registry update: 1 Oct 2026
NCT07689656
Recruiting
A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer
Phase 1/2 · China · 1 site
Registry update: 8 Jul 2026
NCT07546578
Recruiting
Setting Up ctDNA Analysis on Archived Plasma Samples
Not applicable · Italy · 1 site
Registry update: 11 Sept 2026
2025-525127-27-00
Recruiting
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients with Generalized Myasthenia Gravis
Phase 1/2 · Denmark, Spain, Poland · 20 sites
Registry update: 13 Oct 2026
2025-522362-78-00
Recruiting
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
Phase 4 · Germany, Denmark, Spain, Italy, Poland · 10 sites
Registry update: 30 Oct 2026
2026-525700-10-00
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ST‑905‑AG1 in Healthy Volunteers
Phase 1 · France · 1 site
Registry update: 8 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.